Screener
Medpace Holdings, Inc. MEDP EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Medpace Holdings, Inc.’s reported figures.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
FAQ
- What is Medpace Holdings, Inc.'s EBITDA?
- Medpace Holdings, Inc. (MEDP) reported EBITDA of $153.53M in Q2 2026.
- How has Medpace Holdings, Inc.'s EBITDA changed year-over-year?
- Medpace Holdings, Inc.'s EBITDA increased by 15.1% year-over-year, from $133.35M to $153.53M.
- What is the long-term trend for Medpace Holdings, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s EBITDA has grown at a 26.5% compound annual growth rate (CAGR), from $219.73M to $563.06M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Medpace Holdings, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude